Treatment Outcomes of a Stage 1 Cognitive-behavioral Trial to Reduce Alcohol Use Among Human Immunodeficiency Virus-infected Out-patients in Western Kenya
Overview
Authors
Affiliations
Aims: Dual epidemics of human immunodeficiency virus (HIV) and alcohol use disorders, and a dearth of professional resources for behavioral treatment in sub-Saharan Africa, suggest the need for development of culturally relevant and feasible interventions. The purpose of this study was to test the preliminary efficacy of a culturally adapted six-session gender-stratified group cognitive-behavioral therapy (CBT) intervention delivered by paraprofessionals to reduce alcohol use among HIV-infected out-patients in Eldoret, Kenya.
Design: Randomized clinical trial comparing CBT against a usual care assessment-only control.
Setting: A large HIV out-patient clinic in Eldoret, Kenya, part of the Academic Model for Providing Access to Healthcare collaboration.
Participants: Seventy-five HIV-infected out-patients who were antiretroviral (ARV)-initiated or ARV-eligible and who reported hazardous or binge drinking.
Measurements: Percentage of drinking days (PDD) and mean drinks per drinking days (DDD) measured continuously using the Time line Follow back method.
Findings: There were 299 ineligible and 102 eligible out-patients with 12 refusals. Effect sizes of the change in alcohol use since baseline between the two conditions at the 30-day follow-up were large [d=0.95, P=0.0002, mean difference=24.93, 95% confidence interval (CI): 12.43, 37.43 PDD; d=0.76, P=0.002, mean difference=2.88, 95% CI: 1.05, 4.70 DDD]. Randomized participants attended 93% of the six CBT sessions offered. Reported alcohol abstinence at the 90-day follow-up was 69% (CBT) and 38% (usual care). Paraprofessional counselors achieved independent ratings of adherence and competence equivalent to college-educated therapists in the United States. Treatment effect sizes were comparable to alcohol intervention studies conducted in the United States.
Conclusions: Cognitive-behavioral therapy can be adapted successfully to group paraprofessional delivery in Kenya and may be effective in reducing alcohol use among HIV-infected Kenyan out-patients.
Staton C, Zimmerman A, Pesambili M, Phillips A, Tupetz A, de Souza J PLOS Glob Public Health. 2025; 5(2):e0004200.
PMID: 39913646 PMC: 11801724. DOI: 10.1371/journal.pgph.0004200.
Taylor E, Patel D, Marconi V, Whitmire A, Hansen N, Kershaw T Mil Behav Health. 2024; 11(1-2):66-77.
PMID: 38405355 PMC: 10888529. DOI: 10.1080/21635781.2023.2221465.
Puryear S, Mwangwa F, Opel F, Chamie G, Balzer L, Kabami J J Int AIDS Soc. 2023; 26(12):e26187.
PMID: 38054564 PMC: 10698822. DOI: 10.1002/jia2.26187.
Purgato M, Prina E, Ceccarelli C, Cadorin C, Abdulmalik J, Amaddeo F Cochrane Database Syst Rev. 2023; 10:CD014722.
PMID: 37873968 PMC: 10594594. DOI: 10.1002/14651858.CD014722.pub2.
Parry C, Myers B, Londani M, Shuper P, Janse van Rensburg C, Manda S Addiction. 2023; 118(11):2164-2176.
PMID: 37339811 PMC: 10592292. DOI: 10.1111/add.16278.